CT and MR Imaging of Progressive Dural Involvement by Nephrogenic Systemic Fibrosis

References

1. ↵
   Cowper SE, Robin HS, Steinberg HM, et al. Scleromyxedema-like cutaneous disease in renal-dialysis patients. Lancet 2000;356:1000–01

   CrossRefPubMedWeb of Science
2. ↵
   Cowper SE. The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR). Available at http://www.icnfdr.org. Accessed March 13,2008
3. ↵
   Broome DR. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting. Eur J Radiol 2008;66:230–34

   CrossRefPubMedWeb of Science
4. ↵
   Gibson SE, Farver CF, Prayson RA. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med 2006;130:209–12

   PubMedWeb of Science
5. Kucher C, Steere J, Elenitsas R, et al. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory distress. J Am Acad Dermatol 2006;54:S31–34

   CrossRefPubMedWeb of Science
6. ↵
   Saenz A, Mandal R, Kradin R, et al. Nephrogenic fibrosing dermopathy with involvement of the dura mater. Virchows Arch 2006;449:389–91

   CrossRefPubMedWeb of Science
7. ↵
   Cowper SE, Rabach M, Girardi M. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol 2008;66:191–99

   CrossRefPubMedWeb of Science
8. ↵
   Krous HF, Breisch E, Chadwick AE, et al. Nephrogenic systemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing's sarcoma, end-stage renal disease, and hemodialysis. Pediatr Dev Pathol 2007;10:395–402

   CrossRefPubMedWeb of Science
9. ↵
   Grobner T. Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis [published erratum appears in Nephrol Dial Transplant 2006; 21:1745]. Nephrol Dial Transplant 2006;21:1104–08

   FREE Full Text
10. ↵
    Broome DR, Girgus MS, Baron PW, et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586–92

    CrossRefPubMedWeb of Science
11. ↵
    Wiginton CD, Kelly B, Oto A, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 2008;190:1060–68

    CrossRefPubMedWeb of Science
12. ↵
    Knopp EA, Cowper SE. Nephrogenic systemic fibrosis: early recognition and treatment. Semin Dial 2008;21:123–28

    CrossRefPubMedWeb of Science
13. ↵
    Dorenbeck U, Leingärtner T, Bretschneider T, et al. Tentorial and dural calcification with tertiary hyperparathyroidism: a rare entity in chronic renal failure. Eur Radiol 2002;12:S11–13

    CrossRefWeb of Science